期刊
出版社
MDPI
DOI: 10.3390/ijerph19052877
关键词
COVID-19; SARS-CoV-2; mouthwashes; mouthrinse; aerosols; chlorhexidine; povidone-iodine; cetylpiridinium chloride; hydrogen peroxide; colony-forming units
The use of PVP-I as a pre-intervention mouthwash has been shown to reduce the salivary load of SARS-CoV-2, potentially decreasing the risk of cross-infection in healthcare settings.
The use of pre-procedural rinses has been investigated to reduce the number of viral particles and bacteria in aerosols, potentially decreasing the risk of cross-infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during medical and dental procedures. This review aims to confirm whether there is evidence in the literature describing a reduction in salivary load of SARS-CoV-2 when povidone-iodine (PVP-I) is used as a pre-intervention mouthwash. An search of the MEDLINE, Embase, SCOPUS, and the Cochrane library databases was conducted. The criteria used followed the PRISMA(R) Statement guidelines. Randomized controlled trials investigating the reduction of salivary load of SARS-CoV-2 using PVP-I were included. Ultimately, four articles were included that met the established criteria. According to the current evidence, PVP-I is effective against SARS-CoV-2 in saliva and could be implemented as a rinse before interventions to decrease the risk of cross-infection in healthcare settings.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据